Who Really Put Peptides on the Restricted List — And Why They’re Coming Back
// Market Update · Regulatory History · FDA Framework · Titanborn Research // Editorial Note This article covers documented regulatory history based on published FDA guidance, Federal Register notices, and independent journalism. All facts are sourced and verifiable. This is educational content — not legal or political advice. In September 2023, the FDA restricted compounding…